Skip to main content

A Multicentre, Single-Arm, Phase 3b Study to Assess Changes in Symptoms in Adult Participants with Chronic Rhinosinusitis with Nasal Polyposis Initiating Treatment with Tezepelumab (ESSENCE)

Open
  • Protocol code: D5242C00002
  • EudraCT code: No aplica
  • Service: ENT
  • Principal investigator:  Salazar Guilarte, Jhonder Xavier
  • Pathology: Malalties de la oïda i de l’apòfisi mastoide
  • Phase: Fase III